Article info

Download PDFPDF

Occupational exposure to conventional antineoplastic drugs: can it be further limited?
Free

Authors

  • Nicolas Simon Univ. Lille, CHU Lille, EA 7365 – GRITA – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France Pharmacy, Geneva University Hospitals and School of Pharmaceutical Sciences, University Hospital of Geneva, University of Lausanne, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Pascal Odou Univ. Lille, CHU Lille, EA 7365 – GRITA – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France PubMed articlesGoogle scholar articles
  • Bertrand Décaudin Univ. Lille, CHU Lille, EA 7365 – GRITA – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France PubMed articlesGoogle scholar articles
  • Pascal Bonnabry Pharmacy, Geneva University Hospitals and School of Pharmaceutical Sciences, University Hospital of Geneva, University of Lausanne, Geneva, Switzerland PubMed articlesGoogle scholar articles
  • Sandrine Fleury Souverain Pharmacy, Geneva University Hospitals and School of Pharmaceutical Sciences, University Hospital of Geneva, University of Lausanne, Geneva, Switzerland PubMed articlesGoogle scholar articles

Citation

Simon N, Odou P, Décaudin B, et al
Occupational exposure to conventional antineoplastic drugs: can it be further limited?

Publication history

  • First published December 16, 2019.
Online issue publication 
August 24, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.